EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Ketogenic Interventions in Autosomal Dominant Polycystic Kidney Disease: A Comprehensive Review of Current Evidence

Carla Pezzuoli iD, Giuseppe Biagini iD, Riccardo Magistroni

Nutrients · 2024

DOI: 10.3390/nu16162676 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, 2024. Verfasst von Carla Pezzuoli und 2 weiteren Autor:innen. Beteiligte Einrichtung: Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, 41125 Modena, Italy. Hauptthemen laut MEDLINE: Polycystic Kidney, Autosomal Dominant, Diet, Ketogenic. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 100 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero della Salute, Italian Ministry of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Autosomal Dominant Polycystic Kidney Disease (ADPKD) is a genetic disorder characterized by the development and enlargement of multiple kidney cysts, leading to progressive kidney function decline. To date, Tolvaptan, the only approved treatment for this condition, is able to slow down the loss of annual kidney function without stopping the progression of the disease. Furthermore, this therapy is approved only for patients with rapid disease progression and its compliance is problematic because of the drug’s impact on quality of life. The recent literature suggests that cystic cells are subject to several metabolic dysregulations, particularly in the glucose pathway, and mitochondrial abnormalities, leading to decreased oxidative phosphorylation and impaired fatty acid oxidation. This finding paved the way for new lines of research targeting potential therapeutic interventions for ADPKD. In particular, this review highlights the latest studies on the use of ketosis, through ketogenic dietary interventions (daily calorie restriction, intermittent fasting, time-restricted feeding, ketogenic diets, and exogenous ketosis), as a potential strategy for patients with ADPKD, and the possible involvement of microbiota in the ketogenic interventions’ effect.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Kidney, Autosomal DominantDiet, KetogenicHumansCaloric RestrictionKetosisQuality of LifeFastingDisease Progression

Stichwörter der Autor:innen

ADPKDPKDketogenic dietketosiskidney cystskidney function decline

Autor:innen und Institutionen

  • Clinical and Experimental Medicine PhD Program, University of Modena and Reggio Emilia, 41125 Modena, Italy.
  • Division of Nephrology, Dialysis and Renal Transplantation, Azienda Ospedaliero-Universitaria Policlinico di Modena, 41125 Modena, Italy.
  • Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, 41125 Modena, Italy.
  • Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, 41124 Modena, Italy.

ORCID-Profile: Carla Pezzuoli, Giuseppe Biagini

Förderung

  • Ministero della Salute
  • Italian Ministry of Health

Zitieren

APA

Pezzuoli, C., Biagini, G., & Magistroni, R. (2024). Ketogenic Interventions in Autosomal Dominant Polycystic Kidney Disease: A Comprehensive Review of Current Evidence. Nutrients. https://doi.org/10.3390/nu16162676

Vancouver

Pezzuoli C, Biagini G, Magistroni R. Ketogenic Interventions in Autosomal Dominant Polycystic Kidney Disease: A Comprehensive Review of Current Evidence. Nutrients. 2024. doi:10.3390/nu16162676

BibTeX
@article{Pezzuoli2024,
  author = {Pezzuoli, Carla and Biagini, Giuseppe and Magistroni, Riccardo},
  title = {Ketogenic Interventions in Autosomal Dominant Polycystic Kidney Disease: A Comprehensive Review of Current Evidence},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16162676}
}
Kostenlos starten →